The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Open accessAbstract
Klebsiella pneumoniae strain 11978 was isolated in Turkey in 2001 and was found to be resistant to all β-lactams, including carbapenems. Cloning and expression in Escherichia coli identified five β-lactamases, including two novel oxacillinases. The β-lactamase OXA-48 hydrolyzed imipenem at a high level and was remotely related (less than 46% amino acid identity) to the other oxacillinases. It hydrolyzed penicillins and imipenem but not expanded-spectrum cephalosporins. The blaOXA-48 gene was plasmid encoded and not associated with an integron, in contrast to most of the oxacillinase genes. An insertion sequence, IS 1999, was found immediately upstream of blaOXA-48. Another plasmid that encoded a second oxacillinase gene,blaOXA-47, located inside a class 1 integron was identified in K. pneumoniae 11978. OXA-47 had a narrow spectrum of hydrolysis activity and did not hydrolyze ceftazidime or imipenem, as is found for the β-lactamase (OXA-1) to which it is related. In addition, β-lactamases TEM-1 and SHV-2a were expressed from the same K. pneumoniae isolate. Analysis of the outer membrane proteins of this isolate revealed that it lacked a porin of ca. 36 kDa. Thus, the high-level resistance to β-lactams of this clinical isolate resulted from peculiar β-lactamases and modification of outer membrane proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
Plasmid-Determined AmpC-Type β-Lactamases
Philippon, A., Arlet, G., & Jacoby, G. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.1-11.2002 · Cited by 816
Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli
Kieser, T. (1984) · Plasmid · doi:10.1016/0147-619x(84)90063-5 · Cited by 745
Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam Antibiotics
Medeiros, A. A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s19 · Cited by 587
Bradford, P. A., Urban, C., Mariano, N., Projan, S. J., Rahal, J. J., & Bush, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.563 · Cited by 450
Liu, S. L., Hessel, A., & Sanderson, K. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6874 · Cited by 328
Afzal-Shah, M., Woodford, N., & Livermore, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.583-588.2001 · Cited by 282
Martínez-Martínez, L., Pascual, A., Hernández-Allés, S., Alvarez-Díaz, D., Suárez, A. I., Tran, J., Benedí, V. J., & Jacoby, G. A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1669 · Cited by 250
Naas, T., & Nordmann, P. (1999) · Current Pharmaceutical Design · doi:10.2174/1381612805666230112185101 · Cited by 250
Self-citation
Cited by
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Self-citationUpdated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Multiplex PCR for detection of acquired carbapenemase genes
Poirel, L., Walsh, T. R., Cuvillier, V., & Nordmann, P. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.12.002 · Cited by 1,991
Self-citationLogan, L. K., & Weinstein, R. A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw282 · Cited by 1,584
Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance
Navon-Venezia, S., Kondratyeva, K., & Carattoli, A. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux013 · Cited by 1,286
Tzouvelekis, L. S., Markogiannakis, A., Psichogiou, M., Tassios, P. T., & Daikos, G. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05035-11 · Cited by 1,191
Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae
Martin, R. M., & Bachman, M. A. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00004 · Cited by 1,058
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
Self-citationCarbapenem resistance in Enterobacteriaceae: here is the storm!
Nordmann, P., Dortet, L., & Poirel, L. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.03.003 · Cited by 1,038
Self-citationThe global epidemiology of carbapenemase-producing Enterobacteriaceae
van Duin, D., & Doi, Y. (2017) · Virulence · doi:10.1080/21505594.2016.1222343 · Cited by 1,004
Epidemiology of β-Lactamase-Producing Pathogens
Bush, K., & Bradford, P. A. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-19 · Cited by 938
OXA-48-like carbapenemases: the phantom menace
Poirel, L., Potron, A., & Nordmann, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks121 · Cited by 924
Self-citationRapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Cantón, R., Akóva, M., Carmeli, Y., Giske, C. G., Glupczynski, Y., Gniadkowski, M., Livermore, D. M., Miriagou, V., Naas, T., Rossolini, G. M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03821.x · Cited by 883
Self-citationResistance in Gram-Negative Bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.013 · Cited by 874
Past and Present Perspectives on β-Lactamases
Bush, K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01076-18 · Cited by 832
Evans, B. A., & Amyes, S. G. B. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-13 · Cited by 815
Jacoby, G. A., & Munoz-Price, L. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041359 · Cited by 787
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
David, S., Reuter, S., Harris, S. R., Glasner, C., Feltwell, T., Argimon, S., Abudahab, K., Goater, R., Giani, T., Errico, G., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0492-8 · Cited by 773
Lee, C.-R., Lee, J. H., Park, K. S., Kim, Y. B., Jeong, B. C., & Lee, S. H. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00895 · Cited by 739
Rodríguez-Baño, J., Gutiérrez-Gutiérrez, B., Machuca, I., & Pascual, A. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00079-17 · Cited by 704
.Wyres, K. L., & Holt, K. E. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.04.004 · Cited by 685
EUCAST expert rules in antimicrobial susceptibility testing
Leclercq, R., Cantón, R., Brown, D. F. J., Giske, C. G., Heisig, P., MacGowan, A. P., Mouton, J. W., Nordmann, P., Rodloff, A. C., Rossolini, G. M., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03703.x · Cited by 683
Self-citationThe difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide
Nordmann, P., & Poirel, L. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12719 · Cited by 679
Self-citationTreatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
Doi, Y. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz830 · Cited by 652
Diversity, Epidemiology, and Genetics of Class D β-Lactamases
Poirel, L., Naas, T., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01512-08 · Cited by 632
Self-citationResistance in gram-negative bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.238 · Cited by 535
Interplay between β-lactamases and new β-lactamase inhibitors
Bush, K., & Bradford, P. A. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0159-8 · Cited by 531
Genetic Structures at the Origin of Acquisition of the β-Lactamase bla KPC Gene
Naas, T., Cuzon, G., Villegas, M.-V., Lartigue, M.-F., Quinn, J. P., & Nordmann, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01451-07 · Cited by 515
Self-citationThe β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
Livermore, D. M., & Woodford, N. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.07.008 · Cited by 510
Walther-Rasmussen, J., & Høiby, N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki482 · Cited by 495
The Global Ascendency of OXA-48-Type Carbapenemases
Pitout, J. D. D., Peirano, G., Kock, M. M., Strydom, K.-A., & Matsumura, Y. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-19 · Cited by 478
Modes and Modulations of Antibiotic Resistance Gene Expression
Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., & Courvalin, P. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00015-06 · Cited by 427
“Stormy waters ahead”: global emergence of carbapenemases
Patel, G., & Bonomo, R. A. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00048 · Cited by 423
The rapid spread of carbapenem-resistant Enterobacteriaceae
Potter, R. F., D’Souza, A. W., & Dantas, G. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.09.002 · Cited by 403
Tackling Threats and Future Problems of Multidrug-Resistant Bacteria
Medina, E., & Pieper, D. H. (2016) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2016_492 · Cited by 356
Wang, Q., Wang, X., Wang, J., Ouyang, P., Jin, C., Wang, R., Zhang, Y., Jin, L., Chen, H., Wang, Z., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy660 · Cited by 349
Karampatakis, T., Tsergouli, K., & Behzadi, P. (2023) · Antibiotics · doi:10.3390/antibiotics12020234 · Cited by 339
Treating infections caused by carbapenemase-producing Enterobacteriaceae
Tzouvelekis, L. S., Markogiannakis, A., Piperaki, E., Souli, M., & Daikos, G. L. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12697 · Cited by 337
Tängdén, T., & Giske, C. G. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12342 · Cited by 322
β-Lactamases: A Focus on Current Challenges
Bonomo, R. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025239 · Cited by 318
Cerceo, E., Deitelzweig, S. B., Sherman, B. M., & Amin, A. N. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0220 · Cited by 313
Carbapenemases: Molecular Diversity and Clinical Consequences
Poirel, L., Pitout, J. D., & Nordmann, P. (2007) · Future Microbiology · doi:10.2217/17460913.2.5.501 · Cited by 309
Self-citationClinical Epidemiology, Risk Factors, and Control Strategies of Klebsiella pneumoniae Infection
Chang, D., Sharma, L., Dela Cruz, C. S., & Zhang, D. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.750662 · Cited by 309
Worldwide Diversity of Klebsiella pneumoniae That Produce β-Lactamase blaKPC-2Gene1
Cuzon, G., Naas, T., Truong, H., Villegas, M.-V., Wisell, K. T., Carmeli, Y., Gales, A. C., Navon-Venezia, S., Quinn, J. P., & Nordmann, P. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1609.091389 · Cited by 307
Self-citationEmergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients
Armand-Lefèvre, L., Angebault, C., Barbier, F., Hamelet, E., Defrance, G., Ruppé, E., Bronchard, R., Lepeule, R., Lucet, J.-C., El Mniai, A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01823-12 · Cited by 300
Sawa, T., Kooguchi, K., & Moriyama, K. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-0429-6 · Cited by 296
The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae
van der Bij, A. K., & Pitout, J. D. D. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks214 · Cited by 292
Epidemiology of antimicrobial resistance in bloodstream infections
Akova, M. (2016) · Virulence · doi:10.1080/21505594.2016.1159366 · Cited by 292
Potron, A., Poirel, L., Rondinaud, E., & Nordmann, P. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.31.20549 · Cited by 289
Self-citationCarbapenem Resistance-Encoding and Virulence-Encoding Conjugative Plasmids in Klebsiella pneumoniae
Yang, X., Dong, N., Chan, E. W.-C., Zhang, R., & Chen, S. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2020.04.012 · Cited by 289
Hammoudi Halat, D., & Ayoub Moubareck, C. (2020) · Antibiotics · doi:10.3390/antibiotics9040186 · Cited by 287
Characterization of the Naturally Occurring Oxacillinase of Acinetobacter baumannii
Héritier, C., Poirel, L., Fournier, P.-E., Claverie, J.-M., Raoult, D., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4174-4179.2005 · Cited by 286
Self-citationLan, P., Jiang, Y., Zhou, J., & Yu, Y. (2021) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2021.02.020 · Cited by 280
Spread of OXA-48-Encoding Plasmid in Turkey and Beyond
Carrër, A., Poirel, L., Yilmaz, M., Akan, O. A., Feriha, C., Cuzon, G., Matar, G., Honderlick, P., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01312-09 · Cited by 273
Self-citationCephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii
Héritier, C., Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01320.x · Cited by 266
Self-citationCarbapenem-Resistant Enterobacteriaceae
Iovleva, A., & Doi, Y. (2017) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2017.01.005 · Cited by 263
Carbapenemase-Producing Enterobacteriaceae
Paterson, D., & Doi, Y. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1544208 · Cited by 257
Escalating antimicrobial resistance among Enterobacteriaceae: Focus on carbapenemases
Lynch, J. P., Clark, N. M., & Zhanel, G. G. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1904891 · Cited by 58
Chereau (2015) · doi:10.1128/aac.00029-15 · Cited by 61
Metadata
- Authors
- Poirel, L., Héritier, C., Tolün, V., & Nordmann, P.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2004-01
- Volume
- 48
- Issue
- 1
- Pages
- 15-22
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2099140790
- Cited by
- 997
- References
- 31
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.